E259 - FDA Trials And Tribulations With Connect Biopharma's Barry Quart
Published: June 23, 2025
Duration: 1:04:33
We love to hear from our listeners. Send us a message.
On this week's episode, Barry Quart, CEO of Connect Biopharma, weighs in on the current state of engagement between drug developers and the FDA, and how that key relationship continues to evolve under new leadership. Barry also discusses moving the company from China to San Diego, why a U.S. financial reporting structure helps attract investors, and how Connect is finding the white spaces in respiratory disease -- the company's lead candidate is a biologic drug targeting acute asthma and COPD exacerbations.